Introduction {#S1}
============

Gap junctions are intercellular channels that connect the cytoplasm of adjacent cells, providing a direct intracellular conduit for intercellular communication. A gap junctional channel is formed by two hemichannels; each hemichannel is composed of six subunits (Bennett et al., [@B6]; Harris, [@B46]). Gap junctions exist in both vertebrates and invertebrates. The gap junction proteins in vertebrates are mainly encoded by the connexin gene family, which consists of more than 20 connexin isoforms (Willecke et al., [@B110]), whereas the gap junction proteins in invertebrates are encoded by the unrelated innexin family. Pannexin is an innexin homologous gene and also encodes gap junctional proteins in vertebrates (Bruzzone et al., [@B13]; Baranova et al., [@B3]). However, unlike connexins, pannexins usually form non-junctional membrane channels on the cell surface to provide an intracellular--extracellular conduit and are considered unable to form integral gap junctional channels between cells (Boassa et al., [@B10]; Penuela et al., [@B80]; Sosinsky et al., [@B96]).

Unlike typical ion channels (such as K^+^, Na^+^, and Ca^++^ channels), gap junction channels possess a relatively large pore size (\~10--15 Å) and can allow passage of ions, cell signaling molecules, and small molecules up to \~1.5 kDa (Bennett et al., [@B6]; Harris, [@B46]). This direct intercellular communication pathway plays an important role in embryonic and postembryonic development, cancer suppression, and many physiological and pathological functions. Connexin mutations can cause severe deafness and are responsible for most cases (\> 50%) of hereditary hearing loss in the clinic (Kelsell et al., [@B56]; Zelante et al., [@B118]; Denoyelle et al., [@B31]; Estivill et al., [@B37]; Kelley et al., [@B55]), indicating that connexin gap junctions play a critical role in hearing. Connexin mutations, mutation-induced auditory phenotypes, and gap junctional function in the cochlea have been extensively summarized by previous reviews \[e.g., Zhao et al. ([@B123]), Castillo and Castillo ([@B15]), and Chan and Chang ([@B17])\]. In this review, we mainly focus on the pathogenesis and deafness mechanisms underlying this common hereditary deafness.

Phenotypes of Cx26 (GJB2) Mutation-Induced Hearing Loss {#S2}
=======================================================

Connexin 26 (Cx26, *GJB2*) mutations are a common genetic cause for non-syndromic hearing loss and are responsible for \~50% of non-syndromic hearing loss in children (Rabionet et al., [@B85]). Non-syndromic deafness can be autosomal dominant deafness (DFNA, DFN: deafness; A: dominant), autosomal recessive deafness (DFNB, B: recessive), or X-linked deafness (DFNX, X: X-linked). Each type is numbered in the order in which it was described. The majority of Cx26 mutations are recessive (DFNB1) but a few are dominant (DFNA3). In the clinic, various symptoms and auditory phenotypes are observed. Cx26 mutations can result in a mild-moderate to profound sensorineural hearing loss (Zhao et al., [@B123]; Castillo and Castillo, [@B15]; Chan and Chang, [@B17]). The mutation-induced hearing loss is not always congenital and can be late-onset and progressive, starting or occurring in childhood (Orzan and Murgia, [@B77]; Pollak et al., [@B82]; Gopalarao et al., [@B43]; Chan and Chang, [@B17]). This diversity of clinical appearances implies that hearing loss induced by Cx26 mutations has various pathological changes and different underlying deafness mechanisms.

Functional Analyses of Cx26 Deafness Mutations {#S3}
==============================================

To date, more than 100 *GJB2* mutations have been identified to be associated with deafness \[connexins and deafness Web site: <http://davinci.crg.es/deafness/index.php>, and also see Mani et al. ([@B72]), Castillo and Castillo ([@B15]), and Chan and Chang ([@B17])\]. Functional analyses in transfected cells *in vitro* reveal a variety of pathogenic changes caused by these deafness mutations. (i) Most mutants cannot correctly track to the cell surface to form functional gap junction channels (Martin et al., [@B74]; Choung et al., [@B22]; D'Andrea et al., [@B27]; Thonnissen et al., [@B105]; Bruzzone et al., [@B14]; Wang et al., [@B106]; Bicego et al., [@B9]). (ii) Mutants can also have dominant or trans-dominant negative effects on wild-type (WT) Cx26 and co-expressed Cx30 (Thomas et al., [@B104]; Bicego et al., [@B9]; Deng et al., [@B30]; Palmada et al., [@B78]; de Zwart-Storm et al., [@B28]; Yum et al., [@B117]; Zhang et al., [@B119]). (iii) Some mutants (e.g., p.M34T) can be correctly synthesized and target to the plasma membrane, but cannot form efficient intercellular gap junction channels (Skerrett et al., [@B95]; Bicego et al., [@B9]). (iv) Some mutants retain permeability to ions but not to small molecules. For example, the Cx26 p.V84L mutant is permeable to ions but is impermeable to IP~3~ (Beltramello et al., [@B5]; Zhang et al., [@B120]). (v) Some deafness-associated mutants, such as p.V84L and p.V95M, can form functional homotypic gap junction channels but cannot form functional heterotypic channels (Choung et al., [@B22]; Thonnissen et al., [@B105]; Bruzzone et al., [@B14]; Wang et al., [@B106]), indicating that these mutants may specifically impair heterogeneous channels *in vivo*. A gap junction is formed by two hemichannels. Hemichannels can also solely function on the cell surface to provide an intracellular--extracellular conduit. Connexin hemichannels are usually closed at normal extracellular Ca^++^ level under normal physiological conditions but could be opened under some pathological conditions (Bennett et al., [@B7]; Goodenough and Paul, [@B42]). (vi) Some mutants, e.g., p.G45E, can cause abnormal hemichannel activity and opening at the normal extracellular Ca^++^ level leading to cell lysis and death (Stong et al., [@B98]; Gerido et al., [@B41]). (vii) Finally, it has been reported that the Cx26 p.R75W mutant can impair gap junctional plaque formation and reduce the area of gap junctional plaque and protein levels. The reduction is associated with excessive endocytosis with increased expression of caveolin 1 and 2 (Kamiya et al., [@B54]). However, except for a few mutations, there is no apparent, demonstrable relationship between mutation phenotypes and auditory phenotypes. There is also no definite relationship between mutation-induced specific changes in connexin (channel) functions and phenotypes of mutation-induced deafness. This lack of correspondence suggests that mutation-induced hearing loss is not directly determined by the mutation-induced pathogenic changes in channel function. Other factors, such as compensation and cooperation of other co-expressed connexins and *in vivo* functional impairment, may also play important roles in hearing loss.

Connexin Expression and Function in the Cochlea {#S4}
===============================================

Connexin expression and gap junctional function in the inner ear have been extensively summarized by previous reviews \[e.g., Zhao et al. ([@B123])\]. Here, we briefly summarize main findings and information relevant to this review.

Connexin expression in the cochlea {#S4-1}
----------------------------------

In the cochlea, gap junctions exist extensively in the supporting cells in the organ of Corti, the stria vascularis (SV), the spiral ligament, the spiral limbus, and other cochlear non-sensory cells and structures (Kikuchi et al., [@B57]; Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]) (Figure [1](#F1){ref-type="fig"}). Two independent gap junctional networks have been identified in the inner ear: the epithelial gap junctional network between supporting cells in the auditory sensory epithelium in the organ of Corti and the connective tissue gap junctional network between the connective tissue cells in the cochlear lateral wall (Kikuchi et al., [@B57]). However, there is no connexin expression in hair cells (Kikuchi et al., [@B57]; Zhao and Santos-Sacchi, [@B125]; Zhao and Yu, [@B127]) or gap junctional coupling between outer hair cells (OHCs) and supporting cells (Yu and Zhao, [@B115]) (Figure [1](#F1){ref-type="fig"}).

![**Connexin expression and hypothesized K^+^-recycling in the cochlea**. Cx26 and Cx30 co-localized in supporting cells of the organ of Corti, the spiral limbus (SLM), the stria vascularis (SV), and fibrocytes of the spiral ligament (SPL). Cx31 is localized at type II and IV fibrocytes in the subcentral region (SR) below the spiral prominence (SP). Cx43 is expressed in the bone of the otic capsule. Cx29 is localized only at the Schwann cells wrapping the spiral ganglion neurons in the auditory canal. However, hair cells have no connexin expression. Inset: the organ of Corti. CT, cochlear tunnel; DC, Deiters cell; HC, Hensen cell; IHC, inner hair cell; IPC, inner pillar cell; OHCs, outer hair cells; OPC, outer pillar cell; TM, tectorial membrane; I--V, type I--V fibrocytes. Modified from Forge et al. ([@B38]), Cohen-Salmon et al. ([@B23]), Zhao and Yu ([@B127]), and Liu and Zhao ([@B69]).](fncel-09-00202-g001){#F1}

Multiple connexin genes, *GJB2* (Cx26), *GJB6* (Cx30), *GJB3* (Cx31), *GJC3* (Cx29), and *GJA1* (Cx43), have been identified in the cochlea (Figure [1](#F1){ref-type="fig"}). Cx26 and Cx30 are the predominant isoforms and are widely expressed in the epithelial and connective tissues in a cell-specific and spatiotemporally complex fashion (Kikuchi et al., [@B57]; Lautermann et al., [@B61]; Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]). They are largely co-localized and can form homotypic and heterotypic/heteromeric gap junction channels between native cochlear supporting cells with asymmetrical-rectified gating, which allows one-directional passage (Zhao, [@B121]; Zhao and Santos-Sacchi, [@B126]).

Compared to the extensive expression of Cx26 and Cx30, the expression of other connexins in the cochlea is limited (Figure [1](#F1){ref-type="fig"}). Cx31 has been detected in type III fibrocytes in the spiral ligament in the cochlear lateral wall (Xia et al., [@B111]; López-Bigas et al., [@B71]; Forge et al., [@B38]). Cx29 in the cochlea is expressed on the Schwann cells wrapping the spiral ganglion (SG) neurons (Yang et al., [@B113]; Eiberger et al., [@B33]; Tang et al., [@B101]). Using immunofluorescent staining, Cx43 (*GJA1*) was initially reported on bone of the otic capsule and on cells lining the inside of the bony wall in adult animals (Forge et al., [@B38]; Suzuki et al., [@B100]). However, using *lacZ* reporter gene in Cx43 KO mice, it was found that Cx43 was highly expressed in the connective tissues and weakly expressed in the immature sensory epithelium of the cochlea from embryonic day 15.5 to the first week after birth and was almost exclusively expressed in the bone of the otic capsule after P8 (Cohen-Salmon et al., [@B23]).

Gap junctional function in the cochlea {#S4-2}
--------------------------------------

The hypothetical functions of gap junctions in the cochlea include K^+^-recycling (Santos-Sacchi and Dallos, [@B92]; Santos-Sacchi, [@B90], [@B91]; Kikuchi et al., [@B57]; Spicer and Schulte, [@B97]; Zhao and Santos-Sacchi, [@B124]; Zhao, [@B121]) (Figure [1](#F1){ref-type="fig"}), nutrient and energy supply (Zhao, [@B122]; Zhao et al., [@B128]), intercellular signaling (Beltramello et al., [@B5]; Zhang et al., [@B120]; Zhao et al., [@B128]; Gossman and Zhao, [@B44]), endocochlear potential (EP) generation (Teubner et al., [@B102]; Chen et al., [@B18]), generation and maintenance of the unique electrochemical environments of the endolymph and perilymph (Cohen-Salmon et al., [@B24]; Teubner et al., [@B102]; Chen et al., [@B18]), and participation in active cochlear amplification (Yu and Zhao, [@B115]; Zhu et al., [@B131], [@B130]). Recently, it has been reported that gap junction-mediated intercellular communication also plays an important role in epithelial repair in the cochlea (Forge et al., [@B39]; Jagger et al., [@B52]). Thus, dysfunction of gap junctions or connexin mutations can influence many aspects of cochlear function. For more detailed information, see Sections "[Pathological Changes in the Cochlea in Cx26 Deficient Mice](#S5){ref-type="sec"}," "[Deafness Mechanisms Underlying Cx26 Deficiency Induced Hearing Loss](#S6){ref-type="sec"}," and "[Hearing Loss and Pathological Changes Induced by Mutations of Other Connexins](#S7){ref-type="sec"}."

Hemichannel function in the cochlea {#S4-3}
-----------------------------------

Gap junction hemichannels can also function on the cell surface to provide an intracellular--extracellular conduit. Because hemichannels possess a relatively large pore size, they can release small molecules, such as ATP, which can subsequently activate purinergic P2 receptors to form an extracellular pathway for intercellular signaling. Gap junction hemichannels in the cochlear sensory epithelium can release ATP and IP~3~ and thus participate in intercellular signaling, control of OHC electromotility, K^+^-sinking, and gap junctional coupling (Zhao et al., [@B128]; Gossman and Zhao, [@B44]; Yu and Zhao, [@B114]; Zhu and Zhao, [@B132], [@B133]). It has been reported that some deafness-associated mutants lose permeability to small biochemical molecules, thus impairing intercellular signaling (Beltramello et al., [@B5]; Zhang et al., [@B120]), or cause abnormal hemichannel activity eventually leading to cell lysis and death (Stong et al., [@B98]; Gerido et al., [@B41]). This indicates that gap junctional channels and connexin hemichannels may play an important role in cell signaling in the cochlea.

However, we recently found that Cx26 knockout or Cx30 knockout had little effect on ATP release in the cochlea under normal physiological conditions, while Panx1 deletion can abolish ATP release in the cochlea (Chen et al., [@B20]). These data suggest that pannexin channels rather than connexin hemichannels in the cochlea play an important role under normal physiological conditions.

Connexin-specific function in the cochlea {#S4-4}
-----------------------------------------

Cx26 and Cx30 are predominant connexin isoforms in the cochlea (Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]). It has been found that inner ear gap junctions have strong charge selectivity; Cx26 is associated with anionic permeability in the cochlea (Zhao, [@B122]). This result is consistent with previous reports that Cx26 channels are permeable to both anionic and cationic molecules (Elfgang et al., [@B34]; Manthey et al., [@B73]; Beltramello et al., [@B4]), while Cx30 channels are impermeable to anionic molecules (Manthey et al., [@B73]; Beltramello et al., [@B4]). Thus, Cx26 in the cochlea is mainly responsible for permeability to anions and may play an important role in intercellular signaling, given that most cell signaling molecules (e.g., IP~3~, ATP, cAMP, and cGMP) are anions. This may be a reason why Cx26 but not Cx30 mutations induce high-incidence of hearing loss and why Cx30 knockin cannot restore hearing of Cx26 deficient mice (see Section "[Hearing Restoration in Connexin Deficient Mice](#S9){ref-type="sec"}").

However, functions of other connexins in the cochlea remain largely unclear. Cx29 is expressed on the Schwann cells at the auditory nerve and Cx43 is expressed in the bone. They may be involved in SG neuron activation and bone formation. Cx31 is mainly expressed in the type III fibrocytes in the cochlear lateral wall (Forge et al., [@B38]). Currently, little is known about Cx31 function in the cochlea, even though Cx31 mutations can also induce hearing loss (Liu et al., [@B68]; Oh et al., [@B76]; and also see Section "[Hearing Loss and Pathological Changes Induced by Mutations of Other Connexins](#S7){ref-type="sec"}").

Pathological Changes in the Cochlea in Cx26 Deficient Mice {#S5}
==========================================================

Cx26 and Cx30 are expressed in the cochlea and in the brain. However, cochlear implants can restore hearing function in connexin mutation-induced hearing loss (Rayess et al., [@B86]), indicating major pathological changes in the cochlea.

Pathological changes in the cochlea in Cx26 knockout mice {#S5-1}
---------------------------------------------------------

Based on observations in Cx26 deletion mice, pathological changes of Cx26 deficiency in the cochlea include (i) cochlear developmental disorders, (ii) hair cell and SG neuron degeneration, (iii) EP reduction, and (iv) impairment in active cochlear amplification (Cohen-Salmon et al., [@B24]; Sun et al., [@B99]; Wang et al., [@B109]; Liang et al., [@B65]; Zhu et al., [@B131], [@B130]; Chen et al., [@B18]).

### Cochlear Developmental Disorders in Cx26 Deficient Mice {#S5-1-1}

In mice, the cochlea shows normal morphology and the cochlear tunnel starts to open at postnatal day 5 (P5). By P10, the EP and K^+^ concentration in the endolymph rise to high levels (Ehret, [@B32]; Kraus and Aulbach-Kraus, [@B59]). Hearing starts around P14 and matures at P19--20 (Liang et al., [@B65]) (Figure [2](#F2){ref-type="fig"}). Cx26-null mice are embryonic lethal due to deficiency of transplacental uptake of glucose (Gabriel et al., [@B40]). Using conditional knockout techniques, it has been found that deletion of Cx26 in the cochlea at the embryonic period or P0--1 can cause cochlear developmental disorders (Wang et al., [@B109]; Liang et al., [@B65]; Chen et al., [@B18]). The tectorial membrane attaches at the inner sulcus cells and the under-tectorial-membrane space is lost; the cochlear tunnel is also filled (Figure [3](#F3){ref-type="fig"}A). Recently, we further found that deletion of Cx26 expression in the cochlea before P5 can induce cochlear developmental disorders with congenital deafness (Chen et al., [@B18]). However, with deletion of Cx26 after P5, cochlear development proceeded normally, the cochlear tunnel opened normally, and hearing remained normal at young ages (Chen et al., [@B18]) (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). These data suggest that Cx26 expression in the cochlea at the early postnatal development stage (\<P5) is critical for cochlear postnatal development and maturation.

![**Cochlear postnatal development and functional maturation in mice**. **(A)** Postnatal development of the cochlea. Arrows indicate that the cochlear tunnel starts to open at postnatal day 5 (P5) and fully opens at P10. **(B)** Postnatal developments of endocochlear potential (EP) and \[K^+^\]. Modified from Hibino et al. ([@B47]). **(C)** Hearing maturation in mice. ABR thresholds dramatically drop at P11--16 and reach normal levels around P20. Modified from Liang et al. ([@B65]).](fncel-09-00202-g002){#F2}

![**Cochlear developmental disorders and hearing loss induced by deletion of Cx26 in the cochlea at different postnatal times**. **(A)** Cochlear development after deletion of Cx26 at P1 and P10. White arrows indicate that the cochlear tunnel is filled when Cx26 was deleted at P1 but developed normally when Cx26 was deleted at P10. Empty triangles indicate lack of the under-tectorial-membrane space; the tectorial membrane is attached to the inner sulcus cells following deletion of Cx26 at P1. **(B)** Hearing loss following deletion of Cx26 at different postnatal times. The ABR thresholds were measured at P30 and were normalized to that in WT mice. Corresponding to cochlear developmental disorders, deletion of Cx26 before P5 can induce severe hearing loss. However, hearing remains normal in young mice following deletion of Cx26 after P6. Modified from Chen et al. ([@B18]).](fncel-09-00202-g003){#F3}

![**Normal hearing in young Cx26 KO mice after deletion of Cx26 after birth**. **(A,B)** Immunofluorescent staining for Cx26 in the cochlea in WT and Cx26 KO mice at P30 following deletion of Cx26 at P10. No positive labeling is visible in the Cx26 KO mouse. **(C)** ABR thresholds of WT and Cx26 KO mice were measured at P30 and P90 following deletion of Cx26 at P10. A green arrow indicates that the ABR threshold in Cx26 KO mice at P30 remained normal, even though the expression of Cx26 in the cochlea was already deleted \[see **(B)**\]. At P90, Cx26 KO mice had a significant increase in ABR threshold, displaying hearing loss. \*\*, *P* \< 0.001, *t*-test. Scale bars: 50 μm. Modified from Zhu et al. ([@B130]).](fncel-09-00202-g004){#F4}

### Cochlear Cell Degeneration in Cx26 Deficient Mice {#S5-1-2}

Cx26 deletion in the cochlea can cause hair cell and SG neuron degeneration (Sun et al., [@B99]; Liang et al., [@B65]), even though hair cells have neither connexin expression (Kikuchi, et al., 1995; Zhao and Yu, [@B127]) nor gap junctional coupling (Zhao and Santos-Sacchi, [@B125]; Yu and Zhao, [@B115]). It has been reported that cell degeneration is detectable around P14 (Sun et al., [@B99]; Wang et al., [@B109]). However, substantial hair cell loss is not visible until adulthood. Severe cochlear hair cell loss and SG neuron degeneration also only occurred in middle and basal turns, i.e., in middle and high frequency regions (Sun et al., [@B99]; Wang et al., [@B109]; Liang et al., [@B65]). In addition, functional analyses show that hair cells in Cx26 deficient mice developed normally and retained normal function (Liang et al., [@B65]). So far, the mechanism underlying hair cell and SG neuron degeneration in Cx26 deficient mice remains unclear and needs to be further studied.

### EP Reduction in Cx26 Deficient Mice {#S5-1-3}

Endocochlear potential is a positive voltage (+100--120 mV) in the cochlear endolymph in the scala media (Figure [1](#F1){ref-type="fig"}) and is a driving force for propelling K^+^ ions through transduction channels in hair cells and producing auditory receptor current and potential. Positive EP is required for normal hearing and is generated in the cochlear lateral wall by a complex process (Chen and Zhao, [@B19]; Chen et al., [@B20]). Based on a "two-cell" model, EP generation is initiated at fibrocyte cells in the spiral ligament, where Na^+^/K^+^-ATPases and Na^+^, K^+^, 2Cl^-^ cotransporters depolarize cells to approximately -5 mV. Then, the intermediate cells in the SV are consequently depolarized to approximately -5 mV through gap junctional coupling, which is formed by Cx26 and Cx30 (Liu and Zhao, [@B69]). Since the apical membrane of the intermediate cells have ATP-dependent Kir4.1 K^+^ channels, this will generate a 110--120 mV transmembrane potential (Nernst's K^+^ equilibrium potential) between the intracellular space and the intrastrial space, i.e., +115--125 mV in the intrastrial space with respect to normal extracellular space. Finally, this positive intrastrial potential eventually leads to positive EP (+100--120 mV) in the endolymph in the scala media (Chen and Zhao, [@B19]; Chen et al., [@B20]).

Gap junctional coupling is required for positive EP generation. Deletion of Cx26 expression in the cochlea can cause EP reduction (Cohen-Salmon et al., [@B24]; Chen et al., [@B18]; Zhu et al., [@B130]). In comparison with that of WT mice, EP in Cx26 KO mice was reduced by \~50% (Cohen-Salmon et al., [@B24]; Chen et al., [@B18]). However, EP remained normal following targeted-deletion of Cx26 expression in Deiters supporting cells and outer pillar supporting cells (Zhu et al., [@B131]), which are located around OHCs in the cochlear sensory epithelium (Figure [1](#F1){ref-type="fig"}). This indicates that impairment of the cochlear sensory gap junction network may have little effect on EP generation in the inner ear (Zhu et al., [@B131]; Chen and Zhao, [@B19]; Chen et al., [@B20]).

### Reduction of Active Cochlear Amplification in Cx26 Deficient Mice {#S5-1-4}

Normal hearing relies on active cochlear amplification to increase hearing sensitivity and frequency selectivity (Dallos, [@B26]; Hudspeth, [@B50]). Two forms of active cochlear mechanics have been proposed: one is prestin-based OHC electromotility; another is stereocilium-based hair bundle movement. OHC electromotility serves as a major source of active cochlear amplification in mammals (Brownell et al., [@B12]; Zheng et al., [@B129]; Ashmore, [@B2]). We found that Cx26 deficiency in the cochlear supporting cells can affect OHC electromotility (Yu and Zhao, [@B115]; Zhu et al., [@B131], [@B130]), even though OHCs lack connexin expression and gap junctional coupling (Kikuchi, et al., 1995; Zhao and Santos-Sacchi, [@B125]; Zhao and Yu, [@B127]; Yu and Zhao, [@B115]). OHCs in Cx26 deficient mice still retain normal development and electromotility (Liang et al., [@B65]; Zhu et al., [@B131], [@B130]). However, OHC electromotility was shifted (Zhu et al., [@B131], [@B130]) and active cochlear amplification as measured by distortion product otoacoustic emission (DPOAE) was reduced (Zhu et al., [@B131], [@B130]). Currently, detailed mechanisms for how connexin deficiency in the cochlear supporting cells influences OHC electromotility and eventually reduces active cochlear amplification remain unclear. This needs to be further examined in future studies.

Hearing loss and pathological changes in the cochlea in Cx26 deafness mutation knockin mice {#S5-2}
-------------------------------------------------------------------------------------------

Currently, more than 100 Cx26 deafness mutations have been identified. However, only two Cx26 mutation knockin mouse models have been established. One is Cx26 p.R75W mutation knockin mouse line (Kudo et al., [@B60]), and another is Cx26 p.S17F knockin mouse line (Schütz et al., [@B93]).

Cx26 p.R75W knockin mice are viable. Similar to Cx26 knockout mice, Cx26 p.R75W transgenic mice displayed congenital deafness and cochlear developmental disorders, including filling of the cochlear tunnel (Kudo et al., [@B60]). Cell degeneration is also visible (Kudo et al., [@B60]; Inoshita et al., [@B51]). However, OHCs developed normally and retained normal function, but DPOAE was reduced (Inoshita et al., [@B51]; Minekawa et al., [@B75]).

For Cx26 p.S17F transgenic mice, homozygous mice are not viable, whereas the surviving heterozygous mice show a moderate hearing loss. The auditory brainstem response (ABR) threshold was increased by \~35 dB sound pressure level (SPL) in these mice, and EP was reduced by 20--40% (Schütz et al., [@B93]).

It should be noted that both p.R75W and p.S17F mutations are dominant mutations and cause syndromic hearing loss (Richard et al., [@B88], [@B87]). Functional analyses showed that p.R75W mutation can target to the plasma membrane forming gap junctional plaques between cells, but has no channels function (Chen et al., [@B21]; Zhang et al., [@B119]; Kamiya et al., [@B54]), while p.S17F mutation cannot target to the plasma membrane forming functional gap junction channels or hemichannels (Richard et al., [@B87]; Lee et al., [@B62]). These data further demonstrate that mutation-induced pathological changes in connexin (channel) function are not directly linked to the final auditory phenotypes. These data also suggest that deafness mechanism(s) underlying connexin mutation-induced syndromic and non-syndromic hearing loss may be similar.

Deafness Mechanisms Underlying Cx26 Deficiency Induced Hearing Loss {#S6}
===================================================================

Deletion of Cx26 in the cochlea can cause cochlear developmental disorders, severe hair cell loss, SG neuron degeneration, and EP reduction (Cohen-Salmon et al., [@B24]; Kudo et al., [@B60]; Sun et al., [@B99]; Wang et al., [@B109]; Liang et al., [@B65]; Chen et al., [@B18]). These findings provide invaluable information about pathological changes induced by Cx26 deficiency. However, the underlying deafness mechanism(s) is still unclear. Several deafness mechanisms, such as K^+^-recycling and Ca^++^-wave propagation hypotheses, have been proposed (Kelsell et al., [@B56]; Beltramello et al., [@B5]; Zhao et al., [@B123]). However, Cx26 mutations can cause various hearing loss phenotypes ranging from congenital deafness to late-onset, progressive hearing loss. Apparently, they have different underlying deafness mechanisms (Liang et al., [@B65]; Zhu et al., [@B131], [@B130]; Chen et al., [@B18]).

Hypothesized deafness mechanism for Cx26 deficiency induced hearing loss {#S6-1}
------------------------------------------------------------------------

### Hypothesized K^+^-Recycling Impairment: Not a Principal Deafness Mechanism {#S6-1-1}

During acoustic stimulation, K^+^ ions in the endolymph in the scala media flow into hair cells through the mechano-transduction channels to generate auditory receptor current and potential. Then, K^+^ ions are pumped out to the extracellular space in the perilymph through the hair cell's lateral wall to restore hair cell function. The expelled K^+^ ions are subsequently sunken by cochlear supporting cells and are eventually transported back to the endolymph in the scala media via gap junctional pathways (Figure [1](#F1){ref-type="fig"}). This hypothesized function of gap junctional coupling in the inner ear was proposed about 30 years ago (Santos-Sacchi and Dallos, [@B92]; Kikuchi et al., [@B57]). Later, it was further hypothesized that Cx26 mutations may impair gap junctional coupling and disrupt such K^+^-recycling leading to K^+^ accumulation in the extracellular space near hair cells, thereby eventually damaging hair cells and causing hearing loss (Kelsell et al., [@B56]; Zhao et al., [@B123]). However, this hypothesized deafness mechanism lacks direct experimental evidence, even though it has been widely referred to. As mentioned above, not all Cx26 deafness mutations disrupt permeability of gap junction channels to ions; some deafness mutants can retain permeability to ions. Moreover, Cx26 mutations can cause various phenotypes of hearing loss (Castillo and Castillo, [@B15]; Chan and Chang, [@B17]), indicating that there are different underlying deafness mechanisms. Most importantly, our recent study demonstrates that mice with deletion of Cx26 in the cochlea after birth can retain normal hearing at young ages (Chen et al., [@B18]; Zhu et al., [@B130]) (Figure [4](#F4){ref-type="fig"}). These new data indicate that K^+^-recycling may not be important for hearing, if Cx26 deficiency disrupts the K^+^-recycling. Or, alternatively, the K^+^-recycling is important for hearing but not impaired by Cx26 deletion due to compensation by co-expressed Cx30. In any case, the hypothesized K^+^-recycling disruption cannot be a principal deafness mechanism for Cx26 deficiency induced hearing loss (Zhu et al., [@B130]).

### Hypothesis of Impairment in Propagation of Ca^++^-Waves in the Cochlear Sensory Epithelium {#S6-1-2}

As intercellular channels, gap junctions also play an important role in intercellular signaling and propagation of Ca^++^-waves among cells. The spread of Ca^++^-waves among cells can be enacted by the passage of Ca^++^ and IP~3~ between cells through gap junctions, or by the passage of ATP and IP~3~ through hemichannels and the subsequent activation of P2 purinergic receptors and IP~3~ receptors (Harris, [@B46]; Gossman and Zhao, [@B44]). Because the Cx26 deafness mutant p.R75W can impair the spread of Ca^++^-waves among cells (Beltramello et al., [@B5]; Yum et al., [@B117]; Zhang et al., [@B119]; Kamiya et al., [@B54]), it has been hypothesized that Cx26 deficiency may impair Ca^++^-wave propagation in the cochlea leading to hearing loss (Beltramello et al., [@B5]). However, it is currently unclear how such Ca^++^-wave propagation in the cochlea is related to hearing function and deafness, or whether it physiologically occurs in the cochlea. Moreover, it is unclear whether other deafness mutations can impair such Ca^++^-wave propagation, since some mutants can still form functional gap junctional channels permeable to ions (see above). Finally, similar to the K^+^-recycling disruption hypothesis, our recent finding that after deletion of Cx26 in the cochlea mice can still retain normal hearing at young ages (Chen et al., [@B18]; Zhu et al., [@B130]) (Figure [4](#F4){ref-type="fig"}) indicates that Ca^++^-wave propagation impairment cannot be a principal deafness mechanism for Cx26 deficiency induced hearing loss.

Deafness mechanisms underlying Cx26 deficiency induced congenital deafness {#S6-2}
--------------------------------------------------------------------------

As mentioned above, mouse models show that deletion of Cx26 at birth can cause congenital deafness with cochlear developmental disorders, hair cell degeneration, and EP reduction (Wang et al., [@B109]; Liang et al., [@B65]; Chen et al., [@B18]).

### Cell degeneration is Not a Primary Cause for Cx26 Deficiency Induced Congenital Deafness {#S6-2-1}

In mice, hearing starts at P14 and matures at P19--20. We (Liang et al., [@B65]) found that hearing in Cx26 KO mice is completely absent throughout the whole postnatal developmental period. The threshold of ABR, which is an auditory evoked potential in the brain recorded via electrodes placed on the scalp, was even greater than 110 dB SPL, indicating complete hearing loss. However, substantial hair cell loss was not visible until adulthood, although it has been reported that cell degeneration is detectable at young ages (Sun et al., [@B99]; Wang et al., [@B109]). Moreover, substantial cell degeneration was only visible at the middle and basal turns, i.e., in middle and high frequency regions (Sun et al., [@B99]; Wang et al., [@B109]; Liang et al., [@B65]). However, congenital, complete hearing loss occurred throughout the whole frequency range (Liang et al., [@B65]). Thus, hair cell loss is not a primary cause for Cx26 deficiency induced congenital deafness.

### Congenital Deafness is Not Caused by EP Reduction {#S6-2-2}

Endocochlear potential is also reduced in Cx26 KO mice (Cohen-Salmon et al., [@B24]; Chen et al., [@B18]). However, EP reduction is not associated with hearing loss in Cx26 KO mice. As mentioned above, the ABR threshold in Cx26 KO mice was even greater than 110 dB SPL, demonstrating complete hearing loss (Liang et al., [@B65]; Chen et al., [@B18]). However, the EP in Cx26 KO mice was not completely abolished and had a large variability. In some cases, the EP remained even at higher levels (\>70 mV; Cohen-Salmon et al., [@B24]; Chen et al., [@B18]).

### Cochlear Developmental Disorders are Associated with Congenital Deafness Generation {#S6-2-3}

The congenital deafness in Cx26 KO mice, however, is associated with cochlear developmental disorders (Liang et al., [@B65]; Chen et al., [@B18]) (Figure [3](#F3){ref-type="fig"}). Deletion of Cx26 in the cochlea before P5 could cause cochlear developmental disorders, the cochlear tunnel was filled, and mice had congenital deafness (Chen et al., [@B18]). However, when Cx26 was deleted after P5, the cochlea displayed normal development, the cochlear tunnel was open as normal, and there was no congenital deafness (Chen et al., [@B18]; Zhu et al., [@B130]). These data suggest that congenital deafness induced by Cx26 deficiency is likely to result from cochlear developmental disorders (Figure [3](#F3){ref-type="fig"}). However, the detailed mechanisms for how Cx26 deficiency induces cochlear developmental disorders remain unclear.

Deafness mechanisms underlying Cx26 deficiency induced late-onset hearing loss {#S6-3}
------------------------------------------------------------------------------

Cx26 deficiency can also induce late-onset hearing loss. Using an inducible gene knockout technique, we found that deletion of Cx26 expression in the cochlea after P5 can induce late-onset, progressive hearing loss (Chen et al., [@B18]; Zhu et al., [@B130]). Mice retained normal hearing before P30. Then, hearing loss became apparent and severe at high frequencies (Zhu et al., [@B130]). This progression of hearing loss is similar to late-onset, progressive hearing loss observed in DFNA3 and DFNB1 non-syndromic deafness patients, who have normal hearing in early life, followed by hearing loss starting in childhood (Orzan and Murgia, [@B77]; Pollak et al., [@B82]; Gopalarao et al., [@B43]).

This Cx26 conditional KO mouse shows normal cochlear development and has no substantial hair cell loss (Zhu et al., [@B130]). EP was significantly reduced. However, the EP reduction was not associated with progressive hearing loss (Zhu et al., [@B130]), indicating that the EP reduction is also not a determining factor in Cx26 deficiency induced late-onset hearing loss. However, consistent with DPOAE reduction observed in patients (Engel-Yeger et al., [@B35], [@B36]; Santarelli et al., [@B89]), the mouse model demonstrated a progressive DPOAE reduction, severe at high frequencies; functional analysis also showed that OHC electromotility was shifted (Zhu et al., [@B130]). These data indicate that late-onset hearing loss induced by Cx26 deficiency may result from impairment in active cochlear amplification. However, the underlying cellular mechanism remains undetermined.

Hearing Loss and Pathological Changes Induced by Mutations of Other Connexins {#S7}
=============================================================================

In addition to *GJB2* (Cx26), multiple connexin genes *GJB6* (Cx30), *GJB3* (Cx31), *GJC3* (Cx29), and *GJA1* (Cx43), have been identified in the cochlea. Mutations of these connexin genes can also cause hearing loss, even if they are rare.

Cx30 mutation-induced hearing loss and pathological changes {#S7-1}
-----------------------------------------------------------

Cx30 is a predominant connexin isoform, which is extensively co-expressed with Cx26 in the cochlea (Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]). Cx30 mutations can also induce hearing loss. It has been reported that a 342-kb deletion truncating the *GJB6* (Cx30) gene is associated with non-syndromic hearing loss through either homozygous deletion of Cx30 or digenic inheritance of a Cx30 deletion and a Cx26 mutation (Castillo et al., [@B16]). It has also been reported that the Cx30 missense mutation p.T5M at the N-terminus is associated with autosomal dominant non-syndromic deafness (DFNA3), characterized by late-onset, middle to high frequency hearing loss (Grifa et al., [@B45]). Functional analysis shows that the Cx30 p.T5M mutation can track to the plasma membrane but defective channel activity was observed in dye transfer assay (Common et al., [@B25]; Berger et al., [@B8]). The mutation can also impair permeability to IP~3~ (Zhang et al., [@B120]).

It has been found that Cx30 p.A40V and p.I248V can also cause non-syndromic hearing loss (Yang et al., [@B112]; Oh et al., [@B76]). Wang et al. ([@B107]) reported that Cx30 p.A40V mutation could not target to the plasma membrane and accumulated in the Golgi body. The mutant also exerted a dominant negative effect on both WT Cx30 and Cx26, which impaired gap junction formation. However, a recent report (Oh et al., [@B76]) showed that both p.A40V and p.I248V deafness mutations could target to the plasma membrane to form gap junctional channels; they were permeable to calcium ions, but reduced permeability to propidium iodide dye.

Cx30^T5M/T5M^ knockin mice exhibited a mild, but significant increase in their hearing thresholds of about 15 dB at all frequencies (Schütz et al., [@B94]). Western blot analysis showed significantly downregulated expression levels of Cx26 and Cx30. However, Cx26 and Cx30 retained normal distribution patterns. The cochlea and EP also developed normally. Electrical coupling, probed by dual patch-clamp recordings, was normal. However, transfer of the fluorescent tracer calcein between cochlear non-sensory cells was reduced (Schütz et al., [@B94]).

Cx30 knockout mice also show deafness with absence of EP (Teubner et al., [@B102]; Chen et al., [@B18]). After P18, the cochlear sensory epithelium starts to degenerate via cell apoptosis (Sun et al., [@B99]). However, it has been found that Cx26 expression at the protein level in this Cx30 KO mouse line also decreased to 30%. Interestingly, restoration of Cx26 expression in this Cx30 KO mouse line by knockin of an external Cx26 copy can rescue its hearing (Ahmad et al., [@B1]). Recently, it has been reported that a new Cx30 conditional KO mouse line, in which half of Cx26 expression is preserved, displays normal hearing (Boulay et al., [@B11]). These data imply that hearing loss in Cx30 KO mice may result from the accompanied reduction in Cx26 expression. Currently, it is still unclear whether sole Cx30 deletion can induce hearing loss.

Cx31 mutation-induced hearing loss and pathological changes {#S7-2}
-----------------------------------------------------------

The Cx31 mutations can cause both recessive and dominant non-syndromic hearing loss, characterized by late-onset moderate deafness affecting high frequencies (Liu et al., [@B68]; Oh et al., [@B76]). Functional analyses showed that some deafness mutations (e.g., p.V27M, p.V43M, and p.V84I) could target to the plasma membrane to form gap junctional plaques but lost permeability to dyes and ions (Oh et al., [@B76]). It has also been reported that deafness mutation Cx31 p.V174M cannot target to the plasma membrane and accumulated in the lysosomes in the mutant-transfected HeLa cells (Li et al., [@B64]). The mutant could also impair Cx26 WT intracellular trafficking to the plasma membrane, but did not influence trafficking of Cx31 WT (Li et al., [@B64]). Cx31 deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing (Plum et al., [@B81]).

Cx29 mutation-induced hearing loss and pathological changes {#S7-3}
-----------------------------------------------------------

Cx29 mutations can also cause non-syndromic hearing loss (Hong et al., [@B48]; Wang et al., [@B108]). Cx29 KO could result in delay in maturation of hearing threshold, severe loss of myelination, a prolongation in latency and distortion in the wave I of the ABR, loss of high frequency sensitivity, and increased sensitivity to noise damage (Tang et al., [@B101]). However, a study from another group showed that deletion of Cx29 had no effect on hearing (Eiberger et al., [@B33]). The reason for these conflicting results is currently unclear.

Cx43 mutation-induced hearing loss and pathological changes {#S7-4}
-----------------------------------------------------------

Cx43 (*GJA1*) mutations were also initially linked to non-syndromic autosomal recessive deafness (Liu et al., [@B67]). However, it is now clear that the mutations are located in the *GJA1* pseudogene rather than in *GJA1* (Paznekas et al., [@B79]; Hong et al., [@B49]). Recently, a new study (Kim et al., [@B58]) reported that immunofluorescent staining for Cx43 showed strong labeling in the mid-internal auditory canal in the modiolus, which represents the transition zone between Schwann cells and oligodendrocytes. Young Cx43 heterozygous mice (3--4 months old) showed mild-moderate hearing loss (Kim et al., [@B58]). The hearing loss became severe when the mice were old.

Connexin Expression and Pathogenesis in the Human Cochlea {#S8}
=========================================================

Despite extensive studies of connexin expression in the animal cochlea (Kikuchi et al., [@B57]; Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]), little is known about connexin expression in the human inner ear. It has been reported that Cx26 and Cx30 in the human cochlea have similar expression patterns to animals (Liu et al., [@B66]). Recently, by use of the human fetal cochlea, it has been found that the expression of Cx26 and Cx30 is detectable in the outer sulcus cells, but not in the spiral ligament in the cochlear lateral wall at 18 weeks of gestation (Locher et al., [@B70]). However, because of the very limited availability of samples, connexin expression in the human cochlea still remains largely undetermined.

Moreover, although there are numerous clinical reports of connexin mutation-associated hearing loss, there is little description of the pathological changes in humans. Studies of human temporal bone CT imaging showed that approximately 50% of ears of subjects with *GJB2* mutations have temporal bone anomaly (Propst et al., [@B83]; Lee et al., [@B63]). Few studies on the pathogenesis of Cx26 mutations have been done. So far, there is only one case-report of a patient that had Cx26 p.G35delG mutation and p.E101G missense mutation with profound hearing loss (Jun et al., [@B53]). Microscopic observation revealed nearly complete degeneration of hair cells and agenesis of the SV but no neural degeneration. However, other factors, such as aging, cannot be excluded as contributors to these pathological changes. Further studies are needed to define the mutation-associated pathological changes in the human cochlea.

Hearing Restoration in Connexin Deficient Mice {#S9}
==============================================

It has been reported that restoration of Cx26 expression by knockin of an external Cx26 copy in the Cx30 KO mouse line can rescue its hearing, because the Cx26 expression level in the Cx30 KO mice was also dramatically reduced (Ahmad et al., [@B1]). However, Cx30 expression in Cx26 deficient mice was not reduced (Zhu et al., [@B130]), and knockin of an external Cx30 copy in Cx26 deficient mice cannot rescue hearing (Qu et al., [@B84]). Unlike Cx30 knockin, it has been found that knockin of Cx32 (*GJB1*) in Cx26 deficient mice can restore hearing (Degen et al., [@B29]). As mentioned above (Section "[Connexin-Specific Function in the Cochlea](#S4-4){ref-type="sec"}"), permeability of gap junctions and hemichannels in the cochlea is highly charge dependent and Cx26 expression is associated with anionic permeability in the cochlea (Zhao, [@B122]). Cx26 and Cx30 are predominant connexin isoforms in the cochlea (Forge et al., [@B38]; Zhao and Yu, [@B127]; Liu and Zhao, [@B69]). However, Cx26 channels are permeable to both anionic and cationic molecules (Elfgang et al., [@B34]; Manthey et al., [@B73]; Beltramello et al., [@B4]), while Cx30 channels are impermeable to anionic molecules (Manthey et al., [@B73]; Beltramello et al., [@B4]). Thus, Cx26 is able to compensate for Cx30 function, while Cx30 cannot completely compensate for Cx26 function. Cx32 is similar to Cx26 in that it is permeable to both cationic and anionic molecules (Elfgang et al., [@B34]). This may be a reason why Cx32 knockin but not Cx30 knockin can restore hearing function in Cx26 deficient mice. However, the detailed mechanisms need to be further clarified.

Recently, it has also been reported that a genetic approach to restore Cx26 expression in the cochlea in Cx26 KO mice after birth can preserve both hair cells and SG neurons but cannot restore hearing function (Yu et al., [@B116]). This indicates that restoration of hearing function is dependent on not only the level of gene expression but also the timing of gene expression.

Summary and Prospection {#S10}
=======================

Cx26 mutations are the major cause of hereditary deafness and can induce congenital deafness and late-onset hearing loss (Castillo and Castillo, [@B15]; Chan and Chang, [@B17]). Connexin-deletion mouse models show that congenital deafness induced by Cx26 deficiency is associated with cochlear developmental disorders rather than hair cell loss and EP reduction (Liang et al., [@B65]; Chen et al., [@B18]), and that late-onset hearing loss induced by Cx26 deficiency results from the reduction of active cochlear amplification (Zhu et al., [@B131], [@B130]). The new data also demonstrate that the hypothesized K^+^-recycling disruption is not a principal deafness mechanism for Cx26 deficiency induced hearing loss (Chen et al., [@B18]; Zhu et al., [@B130]). These new studies provide a full image of deafness mechanisms for Cx26 mutation-induced hearing loss and also provide important information for developing new protective and therapeutic strategies for this common deafness.

However, the cellular mechanisms underlying Cx26 deficiency induced cochlear developmental disorders remain unclear. The mechanisms whereby Cx26 deficiency in the supporting cells influences OHC electromotility and active cochlear amplification are also unclear. Moreover, it is unknown whether specific mutations of connexins will produce the same pathological changes as connexin knockout mice. Finally, little is known about pathological changes in the human cochlea, and it is unclear whether the observed pathological changes in mice are similar to humans.

Creation of specific connexin mutation knockin mouse models and investigation of pathological changes in the human cochlea are urgently required. The knockin transgenic mice can also provide important information about the relationship between mutated protein expression and absence of protein expression *in vivo*. Recently, it has been reported that administration of vitamins A, C, and E and magnesium ameliorated progressive hearing loss in a child with Cx26 mutation (Thatcher et al., [@B103]). However, the underlying mechanism(s) is not known. These new findings further indicate that a more comprehensive understanding of this common hereditary deafness is important and urgent and will have a tremendous impact on many people, given connexin mutations account for more than 50% of hereditary hearing loss.
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